Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 6417
116th Congress(2019-2020)
Protecting Cures Act of 2020
Introduced
Introduced
Introduced in House on Mar 31, 2020
Overview
Text
Introduced in House 
Mar 31, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Mar 31, 2020)
Mar 31, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 6417 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 6417


To prohibit the Secretary of Health and Human Services from withholding funds for certain research using human fetal tissue, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

March 31, 2020

Ms. Schakowsky (for herself, Mr. Pocan, Mrs. Watson Coleman, Mr. Nadler, Ms. Speier, Ms. DeGette, Ms. Frankel, Ms. DelBene, and Mr. Huffman) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To prohibit the Secretary of Health and Human Services from withholding funds for certain research using human fetal tissue, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protecting Cures Act of 2020”.

SEC. 2. Prohibition against withholding funds in cases of technical and scientific merit.

(a) In general.—In the case of any proposal for research using human fetal tissue, the Secretary of Health and Human Services may not withhold funds because of considerations under subsection (b)(1) of section 492A of the Public Health Service Act (42 U.S.C. 289a–1) if—

(1) the research has been recommended for approval in accordance with paragraphs (1) and (2) of subsection (a) of such section 492A;

(2) the research will be carried out in accordance with section 498A of such Act (42 U.S.C. 289g–1); and

(3) there are reasonable assurances that the research will not utilize any human fetal tissue that has been obtained in violation of section 498B(a) of such Act (42 U.S.C. 289g–2).

(b) Standing approval regarding ethical status.—In the case of any proposal for research using human fetal tissue, the issuance of the report of the Human Fetal Tissue Transplantation Research Panel in December 1988 shall be deemed to be a report—

(1) issued by an ethics advisory board pursuant to section 492A(b)(5)(B)(ii) of the Public Health Service Act (42 U.S.C. 289a–1(b)(5)(B)(ii)); and

(2) finding, on a basis that is neither arbitrary nor capricious, that the nature of the research is such that it is not unethical to conduct or support the research.

(c) Definition.—For purposes of this section, the term “human fetal tissue” has the meaning given such term in section 498A of the Public Health Service Act (42 U.S.C. 289g–1).